Dashboard
Manage Tickers

INDV


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

indivior-reports-rapid-induction-with-sublocade-in-individuals-who-met-criteria-for-moderate-to-severe-opioid-use-disorder
Indivior Reports Rapid Induction With SUBL...
10/15/2025 12:07:41

Rapid induction with SUBLOCADE® showed higher treatment retention rates compared to standard induction, particularly among fent...

craig-hallum-maintains-buy-on-indivior-raises-price-target-to-34
Craig-Hallum Maintains Buy on Indivior, Ra...
08/27/2025 17:54:11

Craig-Hallum analyst Chase Knickerbocker maintains Indivior (NASDAQ:INDV) with a Buy and raises the price target from $27 to...

this-palvella-therapeutics-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday
This Palvella Therapeutics Analyst Begins ...
08/06/2025 12:10:52

hc-wainwright--co-initiates-coverage-on-indivior-with-buy-rating-announces-price-target-of-28
HC Wainwright & Co. Initiates Coverage On ...
08/06/2025 11:14:07

HC Wainwright & Co. analyst Brandon Folkes initiates coverage on Indivior (NASDAQ:INDV) with a Buy rating and announces ...

roblox-carvana-ebay-ch-robinson-worldwide-huntington-ingalls-industries-and-other-big-stocks-moving-higher-on-thursday
Roblox, Carvana, eBay, C.H. Robinson World...
07/31/2025 15:00:57

indivior-raises-fy2025-sales-guidance-from-955000m-1025b-to-1030b-1080b-vs-1009b-est
Indivior Raises FY2025 Sales Guidance from...
07/31/2025 11:03:00

Indivior (NASDAQ:INDV) raises FY2025 sales outlook from $955.000 million-$1.025 billion to $1.030 billion-$1.080 billion vs $1....

indivior-q2-adj-eps-051-beats-025-estimate-sales-302000m-beat-241667m-estimate
Indivior Q2 Adj. EPS $0.51 Beats $0.25 Est...
07/31/2025 11:02:29

Indivior (NASDAQ:INDV) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.25 by 104...

Core News & Articles
Earnings Scheduled For July 31, 2025
07/31/2025 08:32:50

indivior-publishes-results-in--drug-and-alcohol-dependence-reports-that-examines-demographic-and-clinical-factors-associated-with-ed-visits-among-adults-diagnosed-with-opiod-use-disorder-over-six-month-follow-up-period
Indivior Publishes Results In Drug and Al...
07/23/2025 12:09:26

jefferies-assumes-indivior-at-buy-announces-price-target-of-20
Jefferies Assumes Indivior at Buy, Announc...
07/22/2025 10:38:15

Jefferies analyst Dennis Ding assumes Indivior (NASDAQ:INDV) with a Buy rating and announces Price Target of $20.

craig-hallum-maintains-buy-on-indivior-raises-price-target-to-22
Craig-Hallum Maintains Buy on Indivior, Ra...
06/30/2025 13:27:23

Craig-Hallum analyst Chase Knickerbocker maintains Indivior (NASDAQ:INDV) with a Buy and raises the price target from $15 to...

indivior-will-be-added-as-a-member-of-the-us-small-cap-russell-2000-index-effective-after-the-us-market-opens-today-as-part-of-the-2025-russell-indexes-reconstitution
Indivior Will Be Added As A Member Of The ...
06/30/2025 11:12:59

indivior-presents-data-showing-300-mg-sublocade-may-improve-outcomes-for-opioid-use-disorder-patients-with-heavy-fentanyl-use
Indivior Presents Data Showing 300 mg SUBL...
06/19/2025 13:02:39

A post-hoc analysis demonstrates that buprenorphine exposure with 300 mg SUBLOCADE® (buprenorphine extended-release) may improv...

indivior-to-delist-from-lse-citing-us-revenue-dominance-and-higher-nasdaq-liquidity-in-move-to-streamline-operations
Indivior To Delist From LSE, Citing US Rev...
06/02/2025 06:05:54

In further consideration of Indivior's listing structure, the Board now believes that the London Delisting will be benefici...

Core News & Articles
Addex Therapeutics Announces Milestone As ...
05/12/2025 06:23:58

indivior-announces-new-study-highlighting-monthly-sublocade-as-potential-treatment-option-for-opioid-use-disorder-during-and-after-pregnancy
Indivior Announces New Study Highlighting ...
05/01/2025 14:35:45

SUBLOCADE use during pregnancy showed no increased risk of birth defects, miscarriage, or maternal complications compared to ge...

Core News & Articles
Earnings Scheduled For April 24, 2025
04/24/2025 08:32:27

indivior-reaffirms-2025-guidance-expects-net-revenue-of-995m-1025b-vs-1046b-est-sees-adj-gross-profit-of-185m-225m
Indivior Reaffirms 2025 Guidance: Expects ...
04/24/2025 06:18:42

FY 2025 Guidance Unchanged The Company's guidance for FY 2025 under U.S. GAAP is unchanged. Guidance assumes no material ch...

indivior-q1-adj-eps-041-beats-024-estimate-sales-26600m-beat-26235m-estimate
Indivior Q1 Adj. EPS $0.41 Beats $0.24 Est...
04/24/2025 06:05:37

Indivior (NASDAQ:INDV) reported quarterly earnings of $0.41 per share which beat the analyst consensus estimate of $0.24 by 70....

a-look-at-indiviors-upcoming-earnings-report
A Look at Indivior's Upcoming Earnings Report
04/23/2025 21:02:39

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION